A mainstay treatment for gout, probenecid has been shown to function by inhibition of membrane transporters including those for organic anions (OAT) [13], [14], drug efflux [15] and more recently, pannexin 1 (Panx1) [16]. This evidence concerns the gene PANX1 and gout.